By Josh White
Date: Friday 06 Jun 2025
(Sharecast News) - N4 Pharma reported a reduced operating loss of £1.22m for 2024 on Friday, down from £1.42m the prior year, as the biotech company continued to develop its proprietary Nuvec gene delivery platform.
By Josh White
Date: Wednesday 04 Dec 2024
(Sharecast News) - N4 Pharma, a pharmaceutical company specializing in RNA therapeutics, announced the filing of a new patent with the UK patent office on Wednesday, for its oral anti-inflammatory treatment targeting irritable bowel disease (IBD).
By Josh White
Date: Tuesday 20 Aug 2024
(Sharecast News) - N4 Pharma, a specialist pharmaceutical company focused on the development of Nuvec, a novel delivery system for cancer treatments, gene therapy, and vaccines, updated the market on its collaboration with SRI International on Tuesday.
Currency | UK Pounds |
Share Price | 0.38p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.07 |
52 Week Low | 0.35 |
Volume | 0 |
Shares Issued | 832.28m |
Market Cap | £3.12m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research